PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 4 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report Sensorion reports 2024 first half results including progress on SENS-501 and SENS-401 programs. Cash position strong at €87m. Future milestones and financial highlights outlined Sensorion Hearing Loss SENS-401 SENS-501 2024 Results
BRIEF published on 09/12/2024 at 07:35, 1 year 4 months ago Sensorion to Present at 59th Inner Ear Biology Workshop Conference Sensorion Hearing Loss Inner Ear Biology Proteomics
PRESS RELEASE published on 09/12/2024 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces participation in the 59th Annual Inner Ear Biology Workshop in Warsaw, Poland. Presentation on SENS-401 and gene therapy programs Gene Therapy Sensorion Hearing Loss SENS-401 Inner Ear Biology Workshop
BRIEF published on 09/02/2024 at 07:35, 1 year 5 months ago Sensorion at the World Congress of Audiology 2024 in Paris Gene Therapy Sensorion Hearing Loss World Congress Of Audiology Medical Symposium
PRESS RELEASE published on 09/02/2024 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion to lead symposium on medical advances in hearing loss at World Congress of Audiology in Paris, September 2024 Sensorion Hearing Loss Symposium World Congress Of Audiology Medical Advances
BRIEF published on 08/05/2024 at 07:35, 1 year 6 months ago Sensorion to Participate in Stifel's Biotech Summer Summit Investment Gene Therapy Sensorion Hearing Loss Biotech Summit 2024
PRESS RELEASE published on 08/05/2024 at 07:30, 1 year 6 months ago Inside Information / Other news releases Sensorion to participate in Stifel's Biotech Summer Summit 2024 to discuss strategic developments and gene therapy programs for hearing loss disorders Gene Therapy Sensorion Hearing Loss Disorders Stifel Biotech Summer Summit
BRIEF published on 06/27/2024 at 07:35, 1 year 7 months ago Sensorion Announces Appointment of New Chief Financial Officer Chief Financial Officer Biotechnology Sensorion Hearing Loss Laurene Danon
PRESS RELEASE published on 06/27/2024 at 07:30, 1 year 7 months ago Inside Information / Other news releases Sensorion appoints Laurene Danon as Chief Financial Officer, bringing 15 years of experience in investment banking. The company focuses on developing therapies for hearing loss disorders Chief Financial Officer Investment Banking Sensorion Laurene Danon Hearing Loss Therapies
BRIEF published on 05/30/2024 at 07:35, 1 year 8 months ago Sensorion announces the results of its Combined General Meeting Biotechnology Resolutions General Assembly Sensorion Hearing Therapies
Published on 02/07/2026 at 01:00, 1 day 3 hours ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 5 hours ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 6 hours ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 13 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 15 hours ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/07/2026 at 21:00, 7 hours 57 minutes ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 12 hours 22 minutes ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 12 hours 37 minutes ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 9 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 11 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 1 day 10 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 12 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 18:06, 2 days 10 hours ago Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
